6MWD: 6-min walk distance; CARE-HF: Cardiac Resynchronization-Heart Failure; COMPANION: Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure; CRT-D: Cardiac resynchronization ...
The U.S. cardiac resynchronization therapy market was valued at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Surge in ...
His team tracked data on more than 2,000 patients nationwide who got either an implanted cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) device between ...
It offers details on crucial market processes, such as leading participants. Changes in consumer behavioral patterns have temporarily hindered the market’s growth because the size of the Cardiac ...
As with bradycardia pacing, a number of recognized complications may arise. A recent systematic review of CRT trials found failure to successfully place the LV lead in 7% of implants, procedural ...
His team tracked data on more than 2,000 patients nationwide who got either an implanted cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) device between ...
Researchers examined health data for more than 2,000 U.S. adults with an implanted cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) device implanted ...